ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
Assessing the efficacy of nanofabricated plant-based antifungal formulation against the growth and zearalenone toxin production by Fusarium graminearum.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The study investigates the efficacy of nanoencapsulated antifungal formulation (Ne-CIM) against the growth and zearalenone toxin production by Fusarium graminearum with a detailed mechanism of action. Antifungal and zearalenone toxin inhibitory effects of individual essential oils (EOs) (Carum carvi, and Illicium verum), methyl anthranilate, and their combination (CIM; 1:1:0.5) were recorded in terms of minimum inhibitory concentration (MIC) at (0.80, 0.50, 0.70 and 0.50 µl/ml) and (0.60, 0.40, 0.60 and 0.40 µl/ml) respectively. The antifungal formulation CIM was nanoencapsulated inside the chitosan nanogel and characterized using FTIR, DLS, and XRD. The result revealed that Ne-CIM exhibited elevated antifungal and zearalenone toxin inhibition at 0.40 and 0.30 µl/ml respectively which was found to be superior over the individual EOs and mixture formulation. Further, the mechanism of action of Ne-CIM was also explored by targeting the membrane ergosterol, ion leakage, 260/280 absorbing material, antioxidant enzymes, and carbon source utilization level. The result reveals the remarkable impairment in test biochemical parameters over to control. In addition, the practical applicability of Ne-CIM was investigated using in-situ experiments with inoculated toxigenic F. graminearum in raw material from Withania somnifera. The result revealed that at MIC value Ne-CIM protects 70% of fungal growth and 100% of zearalenone toxin, with remarkable protection from lipid peroxidation. The study recommends the Ne-CIM as a novel green antifungal agent for sustainable management of toxigenic F. graminearum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.